Valuation : Uscom Limited

Market Cap 3.12M 2.24M 1.93M 1.81M 1.65M 3.11M 214M 21.47M 8.38M 108M 8.41M 8.23M 358M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.17M 2.73M 2.56M 2.34M 4.4M 303M 30.39M 11.86M 153M 11.9M 11.64M 507M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.011
0.01
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.15
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 06/03/2011
Corporate Secretary 66 23/05/2016
Corporate Officer/Principal - 27/05/2018
Director TitleAgeSince
Chairman - 31/10/2009
Director/Board Member 66 22/08/2018
Director/Board Member 62 15/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%+9.09%-76.92% 2.24M
-1.35%-1.13%+26.27%+12.02% 230B
+0.18%-1.27%+4.98%-18.16% 152B
+1.51%-1.64%-21.28%+20.04% 132B
+0.36%-7.01%-55.60%-14.34% 67.88B
+0.29%+0.47%+10.90%+15.91% 52B
+0.66%-1.69%-16.47%-14.35% 51.05B
-2.44%-3.25%+22.43%+26.08% 43.38B
-1.56%+0.97%+37.41%+44.08% 40.74B
+1.94%+3.81%-12.45%+46.61% 34.67B
Average +0.87%-0.75%+0.53%+4.10% 80.33B
Weighted average by Cap. -0.14%-1.29%+2.51%+7.86%

Financials

2024 2025
Net sales 3.73M 2.67M 2.3M 2.16M 1.97M 3.72M 256M 25.63M 10M 129M 10.04M 9.82M 428M 2.58M 1.85M 1.59M 1.49M 1.36M 2.57M 177M 17.73M 6.92M 89.26M 6.95M 6.8M 296M
Net income -2.07M -1.49M -1.28M -1.2M -1.1M -2.07M -142M -14.27M -5.57M -71.82M -5.59M -5.47M -238M -3.3M -2.37M -2.04M -1.91M -1.75M -3.29M -226M -22.71M -8.86M -114M -8.9M -8.7M -379M
Net Debt -1.53M -1.1M -946K -887K -810K -1.53M -105M -10.53M -4.11M -52.98M -4.12M -4.03M -176M 1.3M 931K 802K 752K 686K 1.29M 88.94M 8.92M 3.48M 44.9M 3.49M 3.42M 149M
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35